This Week in Health CareSM, March 22, 2017
Every Wednesday, Stateside Associates selects some health care-related state and local events to highlight in This Week in Health Care.
To provide feedback, or for more information about these issues or Stateside Associates’ Health Care Practice, please contact Robert Holden at (703) 525-7466 or firstname.lastname@example.org.
There are no Groups events to report.
The Agency for Health Care Administration will hold a public hearing on March 24 regarding recommendations for the Medicaid preferred drug list. Becky Lukaesko at email@example.com
The Department of Professional and Financial Regulation will accept comments until March 27 regarding proposed amendments to the Illinois Pharmacy Practice Act addressing pharmacist scope of practice. Chris Johnson at firstname.lastname@example.org
The Board of Registration of Allied Health Professions will hold a board meeting on March 23 regarding rules concerning occupational therapist assistants and physical therapist assistants. Tyler Jones at email@example.com
The Senate Health and Pensions Committee will hold a public hearing on March 28 regarding S.B. 538, which prohibits a vaccine containing mercury from being administered to a child or adult in Missouri. Arielle Woodmore at firstname.lastname@example.org
The Senate Committee on Health Care will hold a public hearing on March 23 regarding S.B. 423, which allows physician assistants to dispense controlled substances in schedules III and IV under the Federal Controlled Substances Act. Allison Rollins at email@example.com
The House Committee on Health Care will hold a public hearing on March 24 regarding H.B. 3014, which creates a licensure process for Registered Respiratory Therapists. Allison Rollins at firstname.lastname@example.org
The House Committee on Health and Human Resources will hold a public hearing on March 23 regarding H.B. 3028, which creates the centralized Office of Drug Control Policy under the direction of the Secretary of Department of Health and Human Resources and the supervision of the State Health Officer, and incorporates the West Virginia Poison Control Center as a division. Zack Cairns at email@example.com
The Board of Pharmacy will accept comments until March 28 regarding proposed amendments to the Wyoming Controlled Substances Act Rules and Regulations to update rules concerning records and inventories, prescriptions, administrative inspections, and the Prescription Drug Monitoring Program. Becky Lukaesko at firstname.lastname@example.org